. Depletion of hTERT leads to telomere deprotection without telomere shortening: signalfree end quantitation, meta-TIFs in a second cell line, and cell cycle quantitation. Fig. S2 . Reduction of telomere deprotection after overexpression of hTERT in a second cell line and for an extended period. Fig. S3 . Overexpression of hTERT does not alter cell cycle phase or levels of activation of the ATM DNA damage pathway. Fig. S4 . Genes overexpressed after hTERT expression, expression level controls, and control for hTERT antibody specificity. Table S1 . Silencing RNAs used in knock-down experiments. Table S2 . Primers used for gene-expression studies. Table S3 . Cycling conditions for qRT-PCR. Fig. S1 . Depletion of hTERT leads to telomere deprotection without telomere shortening: signal-free end quantitation, meta-TIFs in a second cell line, and cell cycle quantitation. (A) Quantitation of telomere signal-free ends in HT1080 cells treated with hTERT siRNA, with FISH using a telomere peptide nucleic acid (PNA) probe, as an indication of telomere shortening. Each dot represents a cell, with approximately 200 cells counted for each condition. n.s. = not statistically different. (B) (Left) Western blot using whole cell extracts from MRC5-hTERT-ras cells (hTERT-immortalized, tumorigenic, Ras transformed, p53 mutant), showing depletion of hTERT in cells treated with 2 different hTERT siRNAs for 48 h. Ponceau S is used as a loading control. (Right) Quantitation of percentage of γ-H2AX-associated telomeres from meta-TIF assays in MRC5-hTERT-ras cells treated with hTERT siRNA (mean ± SE; n = 3). *p-value = 0.048, **p-value = 0.0016. (Bottom) Representative images from metaphase-TIF assays using MRC5-hTERT-ras cells with hTERT knock-down. γ-H2AX immunofluorescence in red, telomere FISH in green, chromosomes in blue. (C) Alternative representation of Fig 1G: Quantitation of γ-H2AXassociated telomeres from meta-TIF assays in HT1080 cells treated with hTERT siRNA (n = 3 independent experiments; red bar indicates mean). (D) Quantitation of the proportion of cells in G1, S, and G2/M phases of the cell cycle in HT1080 cells treated with control and hTERT siRNAs, with and without over-expression of a siRNA-resistant hTERT (sR). The average percentage of cells in each phase of the cell cycle is shown (mean ± SE; n = 3). Twotailed unpaired student t-tests were conducted on just the proportion of cells in G1. *p-value < 0.05, n.s. = not statistically different. Figure 5A . Vinculin is used as a loading control. (B) Relative mRNA expression using qRT-PCR showing knock-down of DCLRE1B (Apollo) in GM639 cells with and without over-expression of D712A hTERT, used for quantitation of the percentage of γ-H2AX-associated telomeres from meta-TIF assays in Figure 5F (mean ± SE; n = 3). ****p-value < 0.0001, n.s. = not significantly different. (C) Enlargement of representative fluorescent micrographs of the images shown in Figure 5G , of GM639 cells transiently over-expressing D712A hTERT for 24 hrs, with and without depletion of DCLRE1B (Apollo), with immunofluorescence for Hsp70-1 (red) and TRF2 (green), showing an example colocalization (yellow) in an orthogonal view (with XZ plane shown on top, and YZ plane shown on the right). (D) Alternative representation of data shown in Figure 5H : quantitation of the colocalizations of Hsp70-1 and TRF2 immunofluorescence in GM639 cells over-expressing D712A hTERT, with and without depletion of DCLRE1B (Apollo). (3 independent experiments, n= 300 cells). ****p-value <0.0001. Each dot represents one cell. 
